Established in 2006 as a Community of Reality

Welcome to the Neno's Place!

Neno's Place Established in 2006 as a Community of Reality


Neno

I can be reached by phone or text 8am-7pm cst 972-768-9772 or, once joining the board I can be reached by a (PM) Private Message.

Join the forum, it's quick and easy

Established in 2006 as a Community of Reality

Welcome to the Neno's Place!

Neno's Place Established in 2006 as a Community of Reality


Neno

I can be reached by phone or text 8am-7pm cst 972-768-9772 or, once joining the board I can be reached by a (PM) Private Message.

Established in 2006 as a Community of Reality

Would you like to react to this message? Create an account in a few clicks or log in to continue.
Established in 2006 as a Community of Reality

Many Topics Including The Oldest Dinar Community. Copyright © 2006-2020


    Al-Mansour Pharmaceutical: We lost about 800 million dinars during the past year

    Rocky
    Rocky
    Admin Assist
    Admin Assist


    Posts : 278598
    Join date : 2012-12-21

    Al-Mansour Pharmaceutical: We lost about 800 million dinars during the past year Empty Al-Mansour Pharmaceutical: We lost about 800 million dinars during the past year

    Post by Rocky Tue 02 May 2023, 5:15 am

    Al-Mansour Pharmaceutical: We lost about 800 million dinars during the past year

    [You must be registered and logged in to see this image.]



    [You must be registered and logged in to see this link.] [You must be registered and logged in to see this link.] [You must be registered and logged in to see this link.] [You must be registered and logged in to see this link.]



    Economy News - Baghdad
    Al-Mansour Pharmaceutical Industries announced that it lost about 800 million dinars during the year 2022, after the factory stopped production permanently.
    The company said, in its annual report, which was reviewed by "Al-Iqtisad News", that "there are no revenues during the year 2022 due to the plant's final cessation of production, its rehabilitation and its complete restructuring according to the requirements of the Ministry of Health, after increasing the capital that was spent for rehabilitation purposes."
    She added, "It achieved losses of 799.7 million dinars during the year 2022," stressing that "the company's capital increased from 9.9 billion dinars in the year 2021, to 16 billion dinars in the year 2022."
    She pointed out that "there are several obstacles, including the lack of a clear state policy regarding the pharmaceutical industry, the wide openness of the pharmaceutical market outside the controls and instructions, and fluctuations in the exchange rate of the dollar against the dinar."
     




    Views 20
    Added 05/02/2023 - 12:51 PM
    [You must be registered and logged in to see this link.]

      Current date/time is Sat 05 Oct 2024, 3:37 pm